Aspirin May Reduce Ovarian Cancer Risk

Published Online: Wednesday, June 11, 2014
Follow Pharmacy_Times:
Women who take aspirin regularly may be at a reduced risk for ovarian cancer, the results of a meta-analysis suggest. The study, published online on February 6, 2014, in the Journal of the National Cancer Institute, analyzed data from population-based studies to help determine the association between the use of aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, and acetaminophen and the risk of developing ovarian cancer. The results indicated that regular aspirin use was associated with a reduced risk of ovarian cancer. Among 7 studies that reported frequency of use, daily use of aspirin was associated with a 20% decrease in ovarian cancer risk. In 3 studies that included dose information, low-dose aspirin use (less than 100 mg per day) was associated with a 34% reduction in ovarian cancer risk.

Related Articles
Providing patients with information is key to helping them manage sickle cell disease pain.
Aspirin may reduce the risk of blood clots in patients who cannot use traditional anticoagulants, new research suggests.
Aspirin not only prevents the production of pain-causing compounds in the body, but also triggers an enzyme to speed the reduction of inflammation.
Latest Issues
$auto_registration$